Verge Genomics Announced Milestones In Collaboration With Lilly To Discover And Develop Novel Treatments For ALS; Lilly To Develop Two Targets Identified By Verge Genomics
Verge Genomics Announced Milestones In Collaboration With Lilly To Discover And Develop Novel Treatments For ALS; Lilly To Develop Two Targets Identified By Verge Genomics
Verge Genomics宣布与Lilly合作的里程碑，致力于发现和开发治疗ALS的新型治疗方法；Lilly将开发Verge Genomics确定的两个目标。
— Lilly to Develop Two Targets Identified and Validated Using Verge Genomics' AI-Enabled, All-in-Human CONVERGE Platform
— 莉莉将开发两个使用Verge Genomics的人工智能支持的全人类CONVERGE平台识别和验证的目标
— Demonstration of the Robust Predictive Power of CONVERGE - 83% of Prioritized Targets were Validated in Disease-Relevant Models, a Rate Significantly Higher than Industry Standards
— 展示CONVERGE的强大预测能力 - 83%的优先目标在与疾病相关的模型中得到了验证，验证率显著高于所有板块标准
资讯热榜
更新时间